Nichi-Iko Has An Ally In Argentina On Infliximab

Strikes Deal With Laboratorio Elea To Market Remicade Biosimilar

 
• By David Wallace
Argentina South America Map
Elea will market Nichi-Iko’s infliximab in Argentina • Source: Alamy

More from Deals

More from Business